As ingenious as nature's invention of myelin sheaths within the mammalian nervous system is, as fatal can be damage to this specialized lipid structure. Long-term loss of electrical insulation and of further supportive functions myelin provides to axons, as seen in demyelinating diseases such as multiple sclerosis (MS), leads to neurodegeneration and results in progressive disabilities. Multiple lines of evidence have demonstrated the increasing inability of oligodendrocyte precursor cells (OPCs) to replace lost oligodendrocytes (OLs) in order to restore lost myelin. Much research has been dedicated to reveal potential reasons for this regeneration deficit but despite promising approaches no remyelination-promoting drugs have successfully been developed yet. In addition to OPCs neural stem cells of the adult central nervous system also hold a high potential to generate myelinating OLs. There are at least two neural stem cell niches in the brain, the subventricular zone lining the lateral ventricles and the subgranular zone of the dentate gyrus, and an additional source of neural stem cells has been located in the central canal of the spinal cord. While a substantial body of literature has described their neurogenic capacity, still little is known about the oligodendrogenic potential of these cells, even if some animal studies have provided proof of their contribution to remyelination. In this review, we summarize and discuss these studies, taking into account the different niches, the heterogeneity within and between stem cell niches and present current strategies of how to promote stem cell-mediated myelin repair.
Introduction
The myelin membrane that is produced by Schwann cells in the peripheral-and by oligodendrocytes (OLs) in the central nervous system (CNS) not only possesses insulating properties, enabling accelerated conduction velocity along axons, but also provides trophic and metabolic support for axons (Fünfschilling et al., 2012; Lee et al., 2012) . Myelin and OLs are vulnerable and subject to damage in many disorders including leukodystrophies such as Pelizaeus-Merzbacheror Canavan diseases (Perlman and Mar, 2012) , psychiatric disorders (Mechawar and Savitz, 2016) or major demyelinating diseases, the most prevalent of which is multiple sclerosis (MS) (Kornek and Lassmann, 2003) . In the brain of MS patients, endogenous remyelination does occur in the early stages of disease (Patrikios et al., 2006; Patani et al., 2007; Piaton et al., 2009 ). However, this process, governed by activation, recruitment and differentiation of oligodendrocyte precursor cells (OPCs), increasingly fails with disease progression (Franklin and Gallo, 2014) . Examination of post-mortem brain and spinal cord tissue has provided evidence that OPCs can be readily found in and around MS lesions, but are unable to differentiate into remyelinating OLs, likely due to the presence of inhibitory molecules (Scolding et al., 1998; Wolswijk, 1998; Chang et al., 2000 Chang et al., , 2002 Kuhlmann et al., 2008; Rivera et al., 2010; Kremer et al., 2011) . Whilst years of translational research have produced a large number of drugs to treat MS patients all of these are of immunomodulatory nature, while still no treatment is available to promote CNS repair. Whereas the field has been focusing on OPCs as a repair-mediating cell pool, neural stem cells (NSCs) have been described as additional source for the generation of mature OLs and for axonal remyelination. In this review, we will present recent advances in NSC-mediated oligodendrogenesis from the different stem cell niches in the CNS, taking into account the heterogeneity within and between these niches. Alvarez-Buylla, 1993; Seri et al., 2001; Rivera et al., 2010) . NSCs are derived from radial glial cells during embryonic development and subsequently divide asymmetrically to self-renew and produce progeny that undergo differentiation and migration (Calzolari et al., 2015) . In the subventricular zone (SVZ), lining the lateral ventricles, NSCs (also referred to as SVZ astrocytes or type B cells) that become activated generate transit-amplifying progenitors (TAPs or type C cells), which can differentiate into neuroblasts (type A cells) or glial cells (Lois and Alvarez-Buylla, 1994; Carleton et al., 2003) . Neurons derived from the SVZ usually migrate along the rostral migratory stream to the olfactory bulb in mammals or to the striatum in humans, whereas OLs mostly populate the adjacent corpus callosum (Seri et al., 2006) . The subgranular zone (SGZ) of the hippocampus, located at the interface of the granule cell layer and the hilus in the dentate gyrus, also harbors NSCs (also referred to as SGZ astrocytes) producing progeny termed type D cells (Seri et al., 2004) . These cells divide, thereby giving birth to further progenitors and eventually produce new granular neurons that are incorporated into the granular layer of the dentate gyrus (Laywell et al., 2000) .
The oligodendrogenic potential of SVZ NSCs highly increases in response to demyelinating damage (Nait- Oumesmar et al., 1999 Oumesmar et al., , 2007 Picard-Riera et al., 2002; Menn et al., 2006; Nakatani et al., 2013; Rafalski et al., 2013; Xing et al., 2014; Brousse et al., 2015) . The process of oligodendrogenesis in the SVZ seems to be heterogeneously regulated at different levels based on regional and intracellular differences in regulatory protein expression (Figure 1) . In contrast to the SVZ, SGZ NSCs appear to solely produce neurons unless genetically reprogrammed or trophically manipulated to induce oligodendrogenesis (Figure 2) (Rivera et al., 2006; Jessberger et al., 2008; Jadasz et al., 2012b; Steffenhagen et al., 2012; Chetty et al., 2014; Braun et al., 2015; Sun et al., 2015; Rolando et al., 2016) . Besides those molecules known to exert pro-oligodendrogenic effects on both, parenchymal as well as on NSC-derived oligodendroglial lineages, several factors were identified which exclusively drive oligodendrogenesis from NSCs, a current compilation of which has recently been published (Akkermann et al., 2016) . Importantly, it was demonstrated that SVZ NSC-derived OLs naturally and significantly contribute to remyelination in experimental demyelination such as observed in experimental autoimmune encephalomyelitis (EAE) or following cuprizone application (Menn et al., 2006; Aguirre et al., 2007; Mecha et al., 2013; Xing et al., 2014; Brousse et al., 2015) . Some of these studies even detected significantly higher densities of NSC-derived OLs as compared to OPC-derived OLs in areas of the corpus callosum surrounding the SVZ (Xing et al., 2014; Brousse et al., 2015) . Remarkably, these NSC-derived OLs produced myelin of a normal thickness rather than the thinner myelin wraps usually seen after remyelination. On the other hand, while NSCs can generate OLs in the corpus callosum in response to focal toxin mediated demyelination (Jablonska et al., 2010 ), it appears that under such circumstances these cells are unable to produce myelin sheaths (Kazanis et al., 2017) .
Strategies for the Promotion of NSC-Mediated Myelin Repair
Whilst stem cell transplantation has so far mainly been considered for the treatment of aggressive forms of demyelinating diseases, primarily addressing trophic-and immunomodulatory properties of haematopoietic-or mesenchymal stem cells (Jadasz et al., 2012a) , a feasible and straightforward alternative is the pharmacological activation of endogenous stem cells. A small but growing body of literature has demonstrated that NSCs can be manipulated to increase their oligodendrogenic potential. One week following viral-mediated forced overexpression of the major oligodendroglial transcription factor Olig2 in the SVZ, 50% of infected cells were found to have migrated into the corpus callosum and acquired an oligodendroglial identity, at the expense of neuronal precursor numbers (Hack et al., 2005) . Similarly, nestin-mediated ectopic expression of Olig2 (but not Olig1) also led to a significant increase in SVZ NSC-derived OL numbers with a concomitant 10% increase of myelinated axons in the corpus callosum (Maire et al., 2010) . Also in the SGZ, reprogramming of NSCs towards an oligodendroglial fate was shown by ectopic overexpression of Ascl1/Mash1, and these cells are capable of remyelinating an experimentally induced demyelinated lesion in the hippocampus (Jessberger et al., 2008; Braun et al., 2015) . NSC-derived OL densities are also boosted upon intraventricular infusion of glycogen synthase kinase 3beta (GSK3β) inhibitors, which induce the Wnt/β-catenin pathway, leading to enhanced myelination in development as well as a promotion of remyelination in response to focal demyelination (Azim and Butt, 2011; Azim et al., 2014b) . A recent study has presented a valuable tool for the identification of small molecules that may be used for instructing fate decisions in stem cells (Azim et al., 2017) . Following in silico genomic analysis using the searchable platform-independent expression database/connectivity map (SPIED/ CMAP), it could be shown that intraventricular infusion of LY-294002, a PI3K/Akt inhibitor, promotes oligodendrogenesis at the expense of neurogenesis in the dorsal SVZ and significantly enhances myelination (Azim et al., 2017) . Using the same approach, the group identified another GSK3β inhibitor, CHIR99021, which following intranasal delivery in hypoxic animals results in elevated densities of OLs able to produce myelin (Azim et al., 2017) . Thus, the SPIED/CMAP database allows for the identification of upstream molecules that may be used to activate or inhibit pathways of interest, thereby enabling to quickly and easily determine potential drugs for the treatment of diseases. Importantly, as observed in post-mortem tissue, NSC recruitment and oligodendrogenesis was also shown to occur in brains of aged MS patients (Nait-Oumesmar et al., 2007) . Together, these findings suggest that NSCs in human neurogenic niches could be pharmacologically stimulated in order to acquire an oligodendrogenic fate and thus to contribute to myelin repair. Potential candidate small molecules can then be thoroughly tested in different experimental models, including toxic demyelination models but also models comprising an autoimmune component, such as in EAE, also addressing the most efficient type of administration. Moreover, it would be desirable to determine whether a combination of the identified small molecule together with approved immunomodulatory drugs can yield synergistic regenerative and anti-inflammatory effects. Ideally, suitable small molecules will be able to induce and boost the activation of endogenous NSCs in their niches, that is their production of migratory progenitors capable of populating demyelinated lesions and their subsequent differentiation into myelinating OLs. Based on differences/similarities between NSC-derived and parenchymal OPCs, it will be important to determine whether the small molecules of choice also exert a pro-oligodendroglial differentiation effect on parenchymal OPCs, in which case the beneficial outcome could be additive.
Effect of Aging on NSC Oligodendrogenesis
Thanks to modern medicine, the average life expectancy of humans has considerably been extended. However, aging still takes its toll on the performance and health of our cells. In the aged SVZ there are fewer ventricle-contacting SVZ astrocytes, and cell proliferation and the generation of progenitors (TAPs) are reduced (Hamilton et al., 2013) . Thus, aging leads to a decline in neurogenesis (Kuhn et al., 1996; Bouab et al., 2011; Capilla-Gonzalez et al., 2013; Weissleder et al., 2016) , probably due to increased cell cycle lengths, lower availability of growth factors as well as accumulation of inhibitors (Hamilton et al., 2013) . Surprisingly, research has shown that in contrast to neurogenesis, the production of oligodendroglial cells from both the SVZ and SGZ appears to be rather stable throughout life. Whereas some reports demonstrate that oligodendrogenesis also decreases with age (Bouab et al., 2011) , several other groups found that NSC-mediated oligodendrogenesis remains constant (Bergmann et al., 2012; Capilla-Gonzalez et al., 2013; Weissleder et al., 2016) . Crawford and colleagues used Emx1 fate-mapping to show that while dorsally derived cells display a decline in oligodendrogenesis ventral/lateral populations were found to be unchanged in their oligodendroglial potential compared with those in younger animals (Crawford et al., 2016) . Remarkably, in the aged human brain, it was shown by determining levels of nuclear bomb test-derived 14 C incorporated into genomic DNA that newly born oligodendroglial cells can still be detected at sites around the lateral wall of the SVZ, which may indicate the life-long oligodendroglial potential of NSCs (Ernst et al., 2014) . This observation was supported by a more recent study comparing gene transcripts of SVZ cells in human post-mortem tissue (Weissleder et al., 2016) . While proliferation of SVZ cells in general and the number of Dcx-expressing immature neurons decline with age, Ascl1-and GFAP-expressing NSCs, as well as Olig2-expressing cells can still be detected in the SVZ in individuals of up to 103 years of age, and these levels are comparable to young adults (Weissleder et al., 2016) .
However, these studies are not based on fate-mapping, and keeping this limitation in mind it cannot be excluded that the oligodendroglial cells detected in and around the SVZ in these tissue samples could be of parenchymal origin and may have migrated to these areas. In contrast to other studies which observed an age-related decline in trophic factors in the human SVZ (Weickert et al., 2000; Chong et al., 2008 ), this report also described an increase or stable expression in transcripts encoding trophic factors or their receptors such as epidermal growth factor (EGF), EGFR, fibroblast growth factor 2 (FGF2) and Erb-B2 receptor tyrosine kinase 4 (ErbB4), which may play a role in maintaining the glial potential of NSCs at later stages of life (Weissleder et al., 2016) . Given the age-related reduction in the regenerative capacity of parenchymal OPCs (van Wijngaarden and Franklin, 2013) , it would therefore be of interest to develop strategies to take advantage of the life-long oligodendrogenic potential of NSCs and to devise means in order to specifically stimulate this cell population for remyelination.
Heterogeneity of NSCs and its Implications for Oligodendrogenesis
The degree of heterogeneity between different populations of NSCs becomes apparent based on the various types of neurons they generate. For example, SVZ NSCs give rise to neuroblasts that migrate to the olfactory bulb to replace GABAergic interneurons (Figure 1 ) (Lois and Alvarez-Buylla, 1994; Carleton et al., 2003) , whereas the progeny of SGZ NSCs differentiate into new glutamatergic granular neurons which integrate into the granular layer of the dentate gyrus (Figure 2) (Laywell et al., 2000) . Therefore, NSC heterogeneity appears to be attributed to different regional requirements but also to be influenced by the local environment. Importantly, NSCs are not only heterogeneous regarding neurogenesis but also regarding oligodendrogenesis. In order to efficiently activate NSCs for the improvement of myelin regeneration, it will be important to understand the distinct oligodendrogenic capacities of different NSC subpopulations. On the other hand, shared pathways and properties may enable simultaneous mobilization to maximize the regenerative effect.
SVZ versus SGZ
The most obvious heterogeneity between SVZ-and SGZ NSCs is that the former tissue gives rise to all three CNS lineages (neurons, astrocytes, oligodendrocytes) under physiological conditions, whereas the latter tissue appears to generate neurons only, unless genetically modified (Jessberger et al., 2008; Sun et al., 2015) or trophically boosted (Rivera et al., 2006) . Indeed, subtle intrinsic regulatory differences might account for these distinct cellular properties and potentials. While promoting neurogenesis in the SGZ (Karalay et al., 2011) , the transcription factor prospero-related homeobox 1 gene (Prox1) was found to drive NSC oligodendrogenesis in the SVZ instead (Figures 1B and 2B) (Bunk et al., 2016) . This discrepancy suggests fundamental differences in the transcriptional network of these cell populations and This heterogeneity of cell progeny is reflected by the regulatory gene expression patterns related to stem cell-mediated oligodendrogenesis. Thus, signaling involving Wnt/β-catenin, prospero-related homeobox 1 gene (Prox1), Olig2, and Sox10 is enriched in the dorsal microdomain of the SVZ, whereas Pbx1 can be detected in the entire niche and p57kip2 appears to be enriched in the lateral SVZ. The latter being a multifunctional protein that has been identified as potent inhibitor of myelinating glial cell differentiation (Kremer et al., 2009; Göttle et al., 2015) as well as being involved in oligodendroglial fate choice of NSCs (Jadasz et al., 2012) . (C) Apart from regional differences in oligodendroglial gene expression between microdomains within the niche, heterogeneity also seems to occur with regard to intracellular protein localization as shown by the example of p57kip2 comparing dorsal (cytoplasmic localization, left blow-up panels) and lateral (nuclear localization, right blow-up panels) zones of the SVZ (scale bar: 50 µm). CC: Corpus callosum. this is further supported by another study reporting that Pbx1 is exclusively expressed in the SVZ where it regulates the balance between neurogenesis and oligodendrogenesis (Grebbin et al., 2016) . Single-cell transcriptome analyses of SVZ-and SGZ NSCs, on the other hand, found positive correlation in gene expression profiles between these populations, suggesting some conservation at least regarding quiescence and activation in different neurogenic niches (Shin et al., 2015; Dulken et al., 2017) . Whilst it was demonstrated that SVZ NSCs have a substantial regenerative and migratory potential following demyelination (Jablonska et al., 2010; Xing et al., 2014; Brousse et al., 2015) , it remains unclear whether SGZ NSCs respond to demyelination by producing OLs without being artificially reprogrammed, and whether these cells can migrate to surrounding white matter tracts.
Dorsal versus lateral microdomains of the SVZ
The different embryonic origins of the walls of the lateral ventricle that form the SVZ explain the heterogeneity found within this neurogenic niche (Fiorelli et al., 2015) . While the dorsal microdomain stems from the pallium, the lateral and medial walls originate from the lateral and medial ganglionic eminences (LGE and MGE), and the septum, respectively (Fiorelli et al., 2015) . SVZ heterogeneity is also reflected by distinct transcriptional profiles which define several different states of NSCs, the two general ones of which are quiescent (associated for example with Sox9, Id2, Id3 and Notch expression) and activated (associated for example with Egr1, Fos, Sox4/11 and Ascl1 expression) (Llorens-Bobadilla et al., 2015) , which can even be subdivided further (Dulken et al., 2017) . The transcriptional profile of NSCs also varies depending on the microdomain within the SVZ, whereby dorsal NSCs are enriched for genes including Emx1 and Tbr2 and the lateral SVZ displays higher expression of markers such as Gsx2 and Dlx2 (Azim et al., 2014a; Llorens-Bobadilla et al., 2015) . These transcriptional signatures correspond to specific neuronal and glial subtypes in NSC progeny. Expression of oligodendroglial transcription factors Olig2 and Sox10 specifically in the dorsal SVZ make this domain the default source for oligodendroglial lineage cells ( Figure  1B) (Ortega et al., 2013; Azim et al., 2014a, b) . Another key regulator of oligodendrogenesis enriched in the dorsal SVZ is Wnt/β-catenin (Ortega et al., 2013; Azim et al., 2014a, b) . Ectopical stimulation of this pathway via either infusion of the agonist Wnt3a, its virus-mediated overexpression, or inhibition of GSK3β leads to the induction of oligodendrogenesis from NSCs in this subdomain ( Figure 1B) (Ortega et al., 2013; Azim et al., 2014a, b) . In line with these findings, Prox1, a target of Wnt signaling, is also predominantly expressed within the dorsal SVZ and is required for NSC oligodendrogenesis (Bunk et al., 2016) . This enrichment in pro-oligodendrogenic signaling molecules in the dorsal SVZ reflects its greater capacity to generate OLs as compared with lateral SVZ NSCs. Whether this heterogeneity is based on the simple fact that the dorsal domain is located closer to the corpus callosum -a white matter tract and a pro-oligodendroglial environment -remains to be investigated. It is also important to take into account the spatial component of the SVZ along the rostro-caudal axis, whereby the surface of the dorsal microdomain becomes larger caudally while the lateral wall is more expanded in the rostral as opposed to the caudal region (Fiorelli et al., 2015) . Therefore, also the density of NSCs within the microdomains varies substantially between these spatial regions (Mirzadeh et al., 2008; Azim et al., 2012) . These heterogeneous profiles of neurogenic-and oligodendrogenic gene expression point towards a fate restriction of specific NSC subpopulations of the SVZ, which occurs early in development and appears to be cell dependent since they do not re-specify when heterotopically transplanted (De Marchis et al., 2007; Merkle et al., 2007; Young et al., 2007) . Nevertheless, also the lateral wall of the SVZ can produce OLs and this can be enhanced for instance by lentiviral expression of Wnt3 (Ortega et al., 2013) , underlining the great potential of this neurogenic niche for myelin regeneration. Likewise, our own studies on the p57kip2 protein which we identified on the one hand as potent intrinsic inhibitor of OPC differentiation (Kremer et al., 2009) , and on the other hand as a fate determinant for NSC-derived oligodendroversus astrogenesis (Jadasz et al., 2012b ) also point to a role in microdomain specification. As shown in Figure 1C higher numbers of p57kip2 expressing cells can be observed in the lateral SVZ microdomain, whereas fewer positive cells reside in the dorsal region (Beyer, Akkermann and Küry, unpublished data) . To what degree a p57kip2 mediated fate determination and/or a blockade of oligodendroglial maturation account for regional differences in efficiently generating OLs remains to be shown in current experiments. Moreover, in parenchymal OPCs we recently demonstrated that not only the expression of p57kip2 as such but its subcellular localization is responsible for controlling oligodendroglial differentiation. While nuclear p57kip2 proteins exert inhibition, cytoplasmic p57kip2 proteins were found to be neutral or to act as pro-oligodendroglial factors (Göttle et al., 2015) , thereby contributing yet another level of heterogeneity which might also be relevant for NSCs ( Figure 1C) . It also remains to be shown whether the increasingly large number of intrinsic negative regulators identified in parenchymal OPCs (Kremer et al., 2011 ) also exert an impact on NSCs at different sites within the SVZ, particularly in light of the fact that for some of them biomedical translation has been developed (Kremer et al., 2016) .
SGZ subpopulations
The SGZ comprises a layer of cells lining the inner granular zone of the dentate gyrus (Figure 2) (Eriksson et al., 1998) . Our knowledge on a potential heterogeneity within this neurogenic niche is still very limited. A recent study, however, has provided evidence of at least two distinct subpopulations of quiescent SGZ NSCs, based on their responsiveness to activating stimuli (Jhaveri et al., 2015) . While both cell populations are characterized by Hes5 and Nestin expression, one of them can be activated by stimulation with the neurotransmitters norepinephrine and dopamine, whereas the other population is activated via depolarizing levels of potassium chloride (KCl) (Jhaveri et al., 2015) . Interestingly, these subpopulations were found to be differentially distributed along the septotemporal axis of the hippocampus, indicating heterogeneity based on the microarchitecture within the niche, similar to the subdivisions in the SVZ. However, unlike SVZ NSCs, SGZ NSCs re-specify when they are heterotopically transplanted, indicating that these cells may not be intrinsically restricted in their fate (Suhonen et al., 1996) . Whether NSCs within the SGZ are also heterogeneous regarding the generation of OLs is not known, as it is still a matter of debate if these cells can spontaneously, that is without any exogenous manipulation, give rise to oligodendroglial cells. Evidence for a primary niche-mediated restriction might be supported by the findings that either ectopical and elevated Ascl1 expression (Jessberger et al., 2008; Braun et al., 2015) or inactivation of p57kip2 (Jadasz et al., 2012b) , Prox1 (Bunk et al., 2016) , Nf1 (Sun et al., 2015) , Drosha (Rolando et al., 2016) or Usp9x (Oishi et al., 2016) induce oligodendrogenesis in SGZ NSCs (Figure 2B ). Based on these differences but also in light of the fact that upon such modulation, SGZ NSC-derived OLs can efficiently remyelinate axons (Braun et al., 2015) , it is possible that these different subpopulations differ in availability or in their responsiveness to pro-oligodendrogenic stimuli and hence are hindered in initiating the differentiation process in situ. Further studies will be needed to unravel potential nuances within this niche in this context.
Spinal cord NSCs
Another source of NSCs, expressing typical markers such as Sox2, Nestin and Vimentin, resides within the ependymal layer of the central canal of the spinal cord (SC; Figure 3A ) (Brundin et al., 2003; Meletis et al., 2008) . The most prominent difference between SC NSCs and those located within the brain is that they are mostly quiescent during homeostatic conditions, with low proliferative activity. In contrast, upon SC injury or in response to EAE, these cells become highly proliferative and give rise to neurons, astrocytes and oligodendrocytes ( Figure 3B ) (Brundin et al., 2003; Danilov et al., 2006; Meletis et al., 2008; Barnabé-Heider et al., 2010) . Interestingly, when heterotopically transplanted into the hippocampus SC NSCs integrated into the granular cell layer and differentiated into neurons typical for this region, indicating that they are not limited to the fate of their origin (Shihabuddin et al., 2000) , which is a common feature of SGZ NSCs (Suhonen et al., 1996) but not of SVZ NSCs (De Marchis et al., 2007; Merkle et al., 2007; Young et al., 2007) . Following SC injury, the contribution of SC NSCs to the astroglial pool is far greater than to the oligodendroglial pool, which could be due to the great density of parenchymal OPCs that produce myelinating OLs in this model (Barnabé-Heider et al., 2010) . However, it was demonstrated that SC NSC-derived OLs myelinated axons in the lesion (Meletis et al., 2008) . Importantly, OLs are also generated from SC NSCs in response to EAE after they (or their progeny) migrated towards demyelinated lesions (Brundin et al., 2003) . These are valuable observations with respect to the frequently observed demyelinated lesions in the SCs of MS patients and the failure of OPCs to replenish the pool of myelinating OLs. Since also the human SC appears to harbor NSCs (Cawsey et al., 2015) , preferentially also in aged or progressive MS patients, pharmacological activation of these cells may provide a strategy to repair SC lesions by enhancing their oligodendroglial differentiation.
NSCs versus parenchymal oligodendroglial lineage cells
Cells of the oligodendroglial lineage are a heterogeneous population with intrinsic cellular differences depending on age and the region within the CNS (Viganò and Dimou, 2016; Moshrefi-Ravasdjani et al., 2017) , a regionalization which is also reflected by differences in gene expression patterns (Marques et al., 2016) . For example, in a recent study OPCs isolated from cortex and SC were cultured on microfibers and the myelin sheaths generated were analyzed. Interestingly, independent of the fiber diameter cells from SC formed myelin sheaths of greater length as compared to cortical cells, indicating intrinsic differences between these two populations (Bechler et al., 2015) . To date, little is known to what extent OPCs/OLs derived from NSCs are different from parenchymal oligodendroglial cells. Given the above-described heterogeneity between different NSC populations and parenchymal oligodendroglial lineage cells, it is not unlikely that NSC progeny display distinct properties with respect to migration, process extension, differentiation, myelin wrapping and the number of axons they interact with. Indeed, Xing and colleagues found differences in the quality of the myelin sheaths produced by NSC-as compared to OPC-derived OLs in response to demyelination (Xing et al., 2014) . A hallmark of remyelination is that produced myelin sheaths are thinner as compared to internodes generated during development (Gledhill and McDonald, 1977) . Remarkably, following cuprizone-induced demyelination, SVZ NSC-derived OLs were found to form myelin sheaths with a thickness indistinguishable from those produced during development (Xing et al., 2014) . It will be crucial to determine the mechanisms behind this finding and whether other NSC populations have the same capacity. It will also be of interest to see whether molecules can be identified that enhance this regenerative capacity and to what degree NSC subpopulations show heterogeneous responses towards such stimulation. Whilst a number of factors have been identified which drive oligodendrogenesis in both NSCs as well as parenchymal OPCs a few were found to exert this effect on NSCs exclusively (Akkermann et al., 2016) . This disparity in the responsiveness of these two cell populations, possibly reflecting differences in certain molecular profiles and pathways, may account for the heterogeneity in oligodendrogenesis between NSCs and OPCs.
Conclusions
Given the endogenous capacity of NSCs to give rise to new myelinating OLs in response to demyelination, as well as the life-long potential of neurogenic niches for oligodendrogenesis pharmacological stimulation of this process is a promising strategy for the establishment of myelin repair approaches. Moreover, manipulation of NSCs has already been shown to effectively enhance remyelination in different contexts (Akkermann et al., 2016) . While one study suggests that NSC progeny is capable of migrating some distances, subsequently taking on a glial fate in the MS brain (Nait- Oumesmar et al., 2007) , the scattered and widespread distribution of lesions along great distances in this context still poses a problem in the process of myelin repair, particularly when taking into account the dimensions of the human CNS. Understanding NSC biology, that is their cellular and molecular characteristics and kinetics, particularly under pathological conditions, will help developing new regenerative strategies in the treatment of demyelinating diseases. A vital aspect in this process is the heterogeneity between different NSC populations, both at the intercellular level within subdomains as well as at the molecular level within each stem cell and its progeny. 
